AngioDynamics, Inc. (ANGO) Overview
- 1 Dec 2025: Period ending 28 Feb 2026; Estimate (m); Actual -0.19; Beat / miss (m).
- 1 Sept 2025: Period ending 30 Nov 2025; Estimate (m); Actual -0.15; Beat / miss (m).
- 1 Jun 2025: Period ending 31 Aug 2025; Estimate (m); Actual -0.26; Beat / miss (m).
- 1 Dec 2024: Period ending 28 Feb 2025; Estimate (m); Actual -0.11; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $11.72
- Previous close
- $15.60
- Change
- -$3.88
- Change (%)
- -24.87%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- ANGO
- +21.50%
- S&P 500
- (m)
1 year
- ANGO
- +45.25%
- S&P 500
- (m)
3 years
- ANGO
- +113.41%
- S&P 500
- (m)
5 years
- ANGO
- -33.22%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
28 Feb 2026 ○ Estimate (m) ● Actual -0.19
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Dec 2025 | 28 Feb 2026 | (m) | -0.19 | (m) | (m) |
| 1 Sept 2025 | 30 Nov 2025 | (m) | -0.15 | (m) | (m) |
| 1 Jun 2025 | 31 Aug 2025 | (m) | -0.26 | (m) | (m) |
| 1 Dec 2024 | 28 Feb 2025 | (m) | -0.11 | (m) | (m) |
| 1 Sept 2024 | 30 Nov 2024 | (m) | -0.26 | (m) | (m) |
31 May 2026 ○ Estimate (m) ● Actual -0.88
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Jun 2025 | 31 May 2026 | (m) | -0.88 | (m) | (m) |
| 1 Jun 2024 | 31 May 2025 | (m) | -0.83 | (m) | (m) |
| 1 Jun 2023 | 31 May 2024 | (m) | -4.59 | (m) | (m) |
| 1 Jun 2022 | 31 May 2023 | (m) | -1.33 | (m) | (m) |
| 1 Jun 2021 | 31 May 2022 | (m) | -0.68 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
31 May 2026 ■ Revenue 86.61M* ■ Earnings -11.40M* — Profit margin -13.17%*
31 May 2026 ■ Revenue 320.17M ■ Earnings -36.74M — Profit margin -11.48%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $11.72 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning ANGO
View more →(m)
Statistics
View more →Retained observations as of 2026-11-11; financial period ending 31 May 2026.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-36.74M
- Operating margin · 12 months
- -12.47%
- Gross margin · 12 months
- 54.62%
- Profit margin
- -11.48%
- Return on assets · 12 month
- -13.43%
- Index membership
- (m)
- Employees
- 632.00
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 486.77K
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- -0.45%*
- Total return · month
- -1.58%*
- Total return · quarter
- 18.18%*
- Total return · half year
- 43.12%*
- Total return · year to date
- 21.50%*
- Total return · 1 year
- 45.25%*
- Total return · 3 years
- 113.41%*
- Total return · 5 years
- -33.22%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- $320.17M
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Free cash flow · 12 months (USD)
- $508.00K
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
AngioDynamics, Inc. Overview
View more →(m)
(m)
- SEC CIK
- 1275187
- Industry (SIC)
- 3841 Surgical & Medical Instruments & Apparatus
- Country of operation
- United States
- Business address
- 14 PLAZA DRIVE, LATHAM, New York, 12110, United States
- Fiscal year end
- 0531
- Phone
- 5187981215
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |